Metabolic characterization of AIDS dementia complex by spectroscopic imaging

Journal of Magnetic Resonance Imaging

Volumn 9, Issue 1, 1999, Pages 10-18

  Möller, Harald E ^a,b   Vermathen, Peter ^d   Lentschig, Markus G ^b   Schuierer, Gerhard ^b   Schwarz, Stefan ^e   Wiedermann, Dirk ^a,b   Evers, Stefan ^c   Husstedt, Ingo W ^c  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b Inst für Klin Radiologie   (Germany)

^c Klinik und Poliklinik fur Neurologie   (Germany)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

Acquired immunodeficiency syndrome; AIDS dementia complex; Chemical shift imaging; Choline; Human immunodeficiency virus; N acetyl L aspartate

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CLINICAL ARTICLE; DEMENTIA; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE;

EID: 0345004149     PISSN: 10531807     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1522-2586(199901)9:1<10::AID-JMRI2>3.0.CO;2-W     Document Type: Article

References (44)

1. Ross BD, Michaelis T. Clinical application of magnetic resonance spectroscopy. Magn Reson Q 1994;10:191-247.
2. 1H NMR spectroscopy: N-acetyl-L-aspartate, creatine and choline. NMR Biomed 1991;4: 47-52.
3. Harrison JG, McArthur JC. AIDS and neurology. Edinburgh: Churchill Livingstone; 1995. p 31-64.
4. Menon DK, Baudouin CJ, Tomlinson D, Hoyle C. Proton MR spectroscopy and imaging of the brain in AIDS: evidence of neuronal loss in regions that appear normal with imaging. J Comput Assist Tomogr 1990;14:882-885.
5. Menon DK, Ainsworth JG, Cox IJ, et al. Proton MR spectroscopy of the brain in AIDS dementia complex. J Comput Assist Tomogr 1992;16:538-542.
6. Jarvik JG, Lenkinski RE, Grossman RI, Gomori JM, Schnall MD, Frank I. Proton MR spectroscopy of HIV-infected patients: characterization of abnormalities with Imaging and clinical correlation. Radiology 1993;186:739-744.
7. 1H magnetic resonance spectroscopic imaging. Neurology 1993;43:509-515.
8. Chong WK, Sweeney B, Wilkinson ID, et al. Proton spectroscopy of the brain in HIV infection: correlation with clinical, immunologic, and MR imaging findings. Radiology 1993;188:119-124.
9. Chong WK, Paley M, Wilkinson ID, et al. Localized cerebral proton MR spectroscopy in HIV infection and AIDS. AJNR Am J Neuroradiol 1994;15:21-25.
10. McConnell JR, Swindells S, Ong CS, et al. Prospective utility of cerebral proton magnetic resonance spectroscopy in monitoring HIV infection and its associated neurological impairment. AIDS Res Hum Retro-viruses 1994;10:977-982.
11. Vion-Dury J, Confort-Gouny S, Nicoli F, et al. Localized brain proton MRS metabolic patterns in HIV-related encephalopathies. C R Acad Sci III 1994;317:833-840.
12. 1H MRSI in cognitively impaired HIV-seropositive individuals. Magn Reson Imaging 1994; 12:653-659.
13. Barker PB, Lee RR, McArthur JC. AIDS dementia complex: evaluation with proton MR spectroscopy imaging. Radiology 1995;195: 58-64.
14. Pavlakis SG, Lu D, Frank Y. et al. Magnetic resonance spectroscopy in childhood AIDS encephalopathy. Pediatr Neurol 1995;12:277-282.
15. Paley M, Wilkinson ID, Hall-Craggs MA, Chong WK, Chinn RJS, Harrison MJG. Short echo time proton spectroscopy of the brain in HIV infection/AIDS. Magn Reson Imaging 1995;13:871-875.
16. Tracey I, Carr CA, Guimaraes AR, Worth JL, Navia BA, Gonzales RG. Brain choline-containing compounds are elevated in HIV-positive patients before the onset of AIDS dementia complex. Neurology 1996;46:783-788.
17. Lu D, Pavlakis SG, Frank Y, et al. Proton MR spectroscopy of the basal ganglia in healthy children and children with AIDS. Radiology 1996;199:423-428.
18. Laubenberger J, Häussinger D, Bayer S, et al. HIV-related metabolic abnormalities in the brain: depiction with proton MR spectroscopy with short echo times. Radiology 1996;199:805-810.
19. Paley M, Cozzone PJ, Alonso J, et al. A multicenter proton magnetic resonance spectroscopy study of neurological complications of AIDS. AIDS Res Hum Retroviruses 1996;12:213-222.
20. English CD, Kaufman MJ, Worth JL. et al. Elevated frontal lobe cytosolic choline levels in minimal or mild AIDS dementia complex patients: a proton magnetic resonance spectroscopy study. Biol Psychiatry 1997;41:500-502.
21. Wilkinson ID, Miller RF, Miszkiel KA, et al. Cerebral proton magnetic resonance spectroscopy in asymptomatic HIV infection. AIDS 1997;11:289-295.
22. Pumarola-Sune T, Navia BA, Cordon-Cardo B, et al. HIV antigen in the brains of patients with AIDS dementia complex. Ann Neurol 1987;21:490-496.
23. Rottenberg DA, Moeller JR, Strother SC, et al. The metabolic pathology of the AIDS dementia complex. Ann Neurol 1987;22:700-706.
24. Kure K, Weidenheim KM, Lyman WD, Dickson DW. Morphology and distribution of HIV-1 gp41-positive microglia in subacute AIDS encephalitis. Pattern of involvement resembling a multisystem degeneration. Acta Neuropathol 1990;80:383-400.
25. Masliah E, Achin CL, Ge N. et al. Spectrum of human immunodeficiency virus-associated neocortical damage. Ann Neurol 1992;32: 321-329.
26. Centers for Disease Control and Prevention. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adults and adolescents. MMWR 1992;41:1-19.
27. 0 filed shifts following the application of pulsed gradients by phase correction in the time domain. J Magn Reson 1986;69:151-155.
28. Nadler JV, Cooper JR. N-acetyl-L-aspartic acid content of human neuronal tumours and bovine peripheral nervous tissues. J Neurochem 1972;19:313-319.
29. 1H NMR markers of neuronal and glial disorders. NMR Biomed 1989;2:196-200.
30. Negendank W. Studies of human tumors by MRS: a review. NMR Biomed 1992;5:303-324.
31. Howe FA, Maxwell RJ Saunders DE, Brown MM, Griffiths JR. Proton spectroscopy in vivo. Magn Reson Q 1993;9:31-59.
32. Shonk TK, Moats RA, Gifford P, et al. Probable Alzheimer disease: diagnosis with proton spectroscopy. Radiology 1995;95:65-72.
33. Ketzler S, Weis S, Haug H, Budka H. Loss of neurons in the frontal cortex in AIDS brains. Acta Neuropathol (Berl) 1990;80:92-94.
34. Wiley CA, Masliah E, Morey M, et al. Neocortical damage during HIV infection. Ann Neurol 1991;29:651-657.
35. Everall IP, Luthert PJ, Lantos PL. Neuronal loss in the frontal cortex in HIV infection. Lancet 1991;337:1119-1121.
36. Everall IP, Luthert, PJ, Lantos PL. Neuronal number and volume alterations in the neocortex of HIV infected individuals. J Neurol Neurosurg Psychiatry 1993;56:481-486.
37. Dal Pan GJ, McArthur JH, Aylward E, et al. Patterns of cerebral atrophy in HIV-1-infected individuals: results of a quantitative MRI analysis. Neurology 1992;42:2125-2130.
38. Aylward EH, Henderer JD, McArthur JC, et al. Reduced basal ganglia volume in HIV-1-associated dementia: results from quantitative neuroimaging. Neurology 1993;43:2099-2104.
39. Gelman BB, Guinto FC. Morphometry, histopathology, and tomography of cerebral atrophy in the acquired immunodeficiency syndrome. Ann Neurol 1992;32:31-40.
40. Budka H. Neuropathology of human immunodeficiency virus infection. Brain Pathol 1991;1:151-155.
41. Bottomley PA, Hardy CJ, Cousins JP, Armstrong M, Wagle WA. AIDS dementia complex: brain high-energy phosphate metabolite deficits. Radiology 1990;176:407-411.
42. Grotemeyer KH, Husstedt IW, Bründermann H, Busch H, Schlake HP, Zidek W. Event-related potentials in HIV-infected outpatients. AIDS Res Hum Retroviruses 1991;7:629-635.
43. Evers S, Husstedt IW, Lüttmann S, Bauer B, Grotemeyer KH. Event-related potentials in HIV infection: evidence for impact of antiretroviral treatment. Arch Neurol 1996;53:715-716.
44. Vion-Dury J, Nicoli F, Salvan AM, Confort-Gouny S, Dhiver C, Cozzone PJ. Reversal of brain metabolic alterations with zidovudine detected by proton localised magnetic resonance spectroscopy. Lancet 1995;345:60-61.